Biofil Chemicals and Pharmaceuticals Limited (NSE:BIOFILCHEM)
36.50
+1.17 (3.31%)
Jun 23, 2026, 3:29 PM IST
NSE:BIOFILCHEM Market Cap
NSE:BIOFILCHEM has a market cap or net worth of 594.32 million as of June 23, 2026. Its market cap has decreased by -26.27% in one year.
Market Cap
594.32M
Enterprise Value
591.26M
Revenue
314.78M
Ranking
n/a
PE Ratio
21.33
Stock Price
36.50
Market Cap Chart
Since December 31, 2001, NSE:BIOFILCHEM's market cap has increased from 34.17M to 594.32M, an increase of 1,639.05%. That is a compound annual growth rate of 12.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2026 | 594.32M | 7.00% |
| Dec 31, 2025 | 555.42M | -40.49% |
| Dec 31, 2024 | 933.30M | 6.14% |
| Dec 29, 2023 | 879.27M | -2.21% |
| Dec 30, 2022 | 899.13M | -11.24% |
| Dec 31, 2021 | 1.01B | -63.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sigachi Industries | 8.77B |
| Bafna Pharmaceuticals | 3.79B |
| Valiant Laboratories | 3.69B |
| Nectar Lifesciences | 2.22B |
| Brooks Laboratories | 1.96B |
| Alpa Laboratories | 1.43B |
| Balaxi Pharmaceuticals | 1.31B |
| Par Drugs and Chemicals | 1.16B |